These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 18407589)
1. Troglitazone, a peroxisome proliferator-activated receptor gamma ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells. Zhou YM; Wen YH; Kang XY; Qian HH; Yang JM; Yin ZF World J Gastroenterol; 2008 Apr; 14(14):2168-73. PubMed ID: 18407589 [TBL] [Abstract][Full Text] [Related]
2. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells. Toyoda M; Takagi H; Horiguchi N; Kakizaki S; Sato K; Takayama H; Mori M Gut; 2002 Apr; 50(4):563-7. PubMed ID: 11889080 [TBL] [Abstract][Full Text] [Related]
4. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells. Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617 [TBL] [Abstract][Full Text] [Related]
5. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity. Baek SJ; Wilson LC; Hsi LC; Eling TE J Biol Chem; 2003 Feb; 278(8):5845-53. PubMed ID: 12475986 [TBL] [Abstract][Full Text] [Related]
6. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms. Pandhare J; Cooper SK; Phang JM J Biol Chem; 2006 Jan; 281(4):2044-52. PubMed ID: 16303758 [TBL] [Abstract][Full Text] [Related]
7. Troglitazone Enhances the Apoptotic Response of DLD-1 Colon Cancer Cells to Photodynamic Therapy. Park H; Ko SH; Lee JM; Park JH; Choi YH Yonsei Med J; 2016 Nov; 57(6):1494-9. PubMed ID: 27593880 [TBL] [Abstract][Full Text] [Related]
8. Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro. Liu JJ; Huang RW; Lin DJ; Peng J; Wu XY; Lin Q; Pan XL; Song YQ; Zhang MH; Hou M; Chen F Ann Oncol; 2005 Mar; 16(3):455-9. PubMed ID: 15642706 [TBL] [Abstract][Full Text] [Related]
9. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand. Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441 [TBL] [Abstract][Full Text] [Related]
10. [Effects of peroxisome proliferator-activated receptor-gamma ligand troglitazone on colon cancer cell growth]. Koirala K; Wan YL; Liu YC; Wang X; Cui W; Wang CL; Chen HN; Wang HY; Zhu J Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):385-8. PubMed ID: 16892143 [TBL] [Abstract][Full Text] [Related]
11. A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells. Akasaki Y; Liu G; Matundan HH; Ng H; Yuan X; Zeng Z; Black KL; Yu JS J Biol Chem; 2006 Mar; 281(10):6165-74. PubMed ID: 16319070 [TBL] [Abstract][Full Text] [Related]
12. Effect of ligand troglitazone on peroxisome proliferator-activated receptor gamma expression and cellular growth in human colon cancer cells. Ming M; Yu JP; Meng XZ; Zhou YH; Yu HG; Luo HS World J Gastroenterol; 2006 Dec; 12(45):7263-70. PubMed ID: 17143939 [TBL] [Abstract][Full Text] [Related]
13. Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity. Yamakawa-Karakida N; Sugita K; Inukai T; Goi K; Nakamura M; Uno K; Sato H; Kagami K; Barker N; Nakazawa S Cell Death Differ; 2002 May; 9(5):513-26. PubMed ID: 11973610 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone. Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274 [TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer. Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607 [TBL] [Abstract][Full Text] [Related]
16. Troglitazone inhibits isolated cell proliferation, and induces apoptosis in isolated rat mesangial cells. Tsuchiya T; Shimizu H; Shimomura K; Mori M Am J Nephrol; 2003; 23(4):222-8. PubMed ID: 12840598 [TBL] [Abstract][Full Text] [Related]
17. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism. Akinyeke TO; Stewart LV Cancer Biol Ther; 2011 Jun; 11(12):1046-58. PubMed ID: 21525782 [TBL] [Abstract][Full Text] [Related]
18. Troglitazone induced apoptosis via PPARγ activated POX-induced ROS formation in HT29 cells. Wang J; Lv X; Shi J; Hu X; DU Y Biomed Environ Sci; 2011 Aug; 24(4):391-9. PubMed ID: 22108328 [TBL] [Abstract][Full Text] [Related]
19. Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR gamma ligand troglitazone. Kawa S; Nikaido T; Unno H; Usuda N; Nakayama K; Kiyosawa K Pancreas; 2002 Jan; 24(1):1-7. PubMed ID: 11741176 [TBL] [Abstract][Full Text] [Related]
20. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo. Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]